Digitally Assisted Rehabilitation at Home for Older Adults After Hip Surgery (GRIMSEL) (GRIMSEL)

June 16, 2026 updated by: Insel Gruppe AG, University Hospital Bern

Digitally Assisted Geriatric Home-rehabilitation in Older Patients After Hip Surgery (GRIMSEL): a Non-inferiority Randomized Controlled Trial

The goal of this clinical trial is to learn if a 12-week digitally supported, multimodal home rehabilitation program using the medical application Akina is as effective compared to routine care regarding functional independence in older adults undergoing hip surgery.

How is this multimodal home rehabilitation program received by patients? Is this multimodal home program at least as effective in terms of functional indpendence, muscle status, mobility and quality of life compared to routine care?

Researchers will compare the multimodal rehabilitation program using the application Akina to routine care to see if the program works to treat patients after hip surgery.

Participants will:

Undergo the rehab program at home or receive routine care (outpatient physiotherapy) for 12 weeks Visit the clinic after 6 and 12 weeks

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Community-dwelling adults aged 55 to 80 years
  • Hospitalized for hip surgery with unrestricted weight bearing at University Hospital Bern

Exclusion Criteria:

  • Discharge to inpatient rehabilitation
  • inability to comply with a rehabilitation program (e.g. comorbidity that prevents 30min light workout, major cognitive impairment)
  • end-of life situation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Routine care
Routine care (outpatient physiotherapy)
Other: routine care
routine care
Experimental: Digitally supported multimodal home rehabilitation
Other: Digitally supported multimodal rehabilitation program
Multimodal personalized rehabilitation program including the medical application Akina and self-managed care based on a geriatric assessment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FIM motor subscale
Time Frame: from baseline (day 1 post-surgery) to follow-up (12 weeks after surgery)

Change of the Functional independence measure (FIM) motor subscale from baseline to follow-up (12 weeks after surgery) between intervention and control group.

The FIM motor subscale is a 13-item assessment tool ranging from a minimum of 13 points (dependence) to a maximum of 91 points (independence)
from baseline (day 1 post-surgery) to follow-up (12 weeks after surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Insel Gruppe AG, University Hospital Bern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

August 1, 2028

Study Registration Dates

First Submitted

June 8, 2026

First Submitted That Met QC Criteria

June 16, 2026

First Posted (Actual)

June 22, 2026

Study Record Updates

Last Update Posted (Actual)

June 22, 2026

Last Update Submitted That Met QC Criteria

June 16, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • BASEC 2026-D0032

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Surgery

Clinical Trials on routine care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe